Interestingly, in highly metastatic MDA-MB-231 breast cancer cells, β–catenin/TCF-4 was shown to stimulate GLI2 promoter activity by binding to TCF-binding element (TBE) within the promoter but only in the presence of active functioning TGF-β/SMAD signaling. The gene discussed is GLI2; the disease is breast carcinoma.